Drovandi, S. Et Al. 2022. Oral Coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary Coenzyme Q10 deficiency. KIDNEY INTERNATIONAL , vol.102, no.3 , 604-612.

Drovandi, S., Lipska-Zietkiewicz, B. S., ÖZALTIN, F., Emma, F., GÜLHAN, B., Boyer, O., ... Trautmann, A.(2022). Oral Coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary Coenzyme Q10 deficiency. KIDNEY INTERNATIONAL , vol.102, no.3, 604-612.

Drovandi, Stefania Et Al. "Oral Coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary Coenzyme Q10 deficiency," KIDNEY INTERNATIONAL , vol.102, no.3, 604-612, 2022

Drovandi, Stefania Et Al. "Oral Coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary Coenzyme Q10 deficiency." KIDNEY INTERNATIONAL , vol.102, no.3, pp.604-612, 2022

Drovandi, S. Et Al. (2022) . "Oral Coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary Coenzyme Q10 deficiency." KIDNEY INTERNATIONAL , vol.102, no.3, pp.604-612.

@article{article, author={Stefania Drovandi Et Al. }, title={Oral Coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary Coenzyme Q10 deficiency}, journal={KIDNEY INTERNATIONAL}, year=2022, pages={604-612} }